Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Treatment Onset Time on Acute Treatment Efficacy in Migraine Patients Using Remote Electrical Neuromodulation (REN)

NCT06976723 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT06976723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06976723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Treatment Onset Time on Acute Treatment Efficacy in Migraine Patients Using Remote Electrical Neuromodulation (REN)
Lead sponsor
Theranica
Phase
Phase 4
Overall status
Completed
Start date
May 7, 2025
Completion date
June 15, 2025
Enrollment
55,261 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute treatment of migraine, migraine